JENNIFER DUBUC: Open Payments
NPI 1831655109 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$388 in 20 payments from 11 companies in 2025. Trend: 2023 $14 · 2024 $19 · 2025 $388
Food & beverage: $388
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $119 |
| ABBVIE INC. | 4 | $74 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| Paratek Pharmaceuticals, Inc. | 1 | $33 |
| Dexcom, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| EVOKE PHARMA, INC. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: Ozempic, DALVANCE, NUZYRA, ZERBAXA, Wegovy, Dexcom G6 Transmitter, PIFELTRO, Kerendia.
Industry payments across LA — which companies pay providers there.
